Immuron
IMRN
4 hedge funds and large institutions have $633K invested in Immuron in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% less ownership
Funds ownership: 0.08% → 0.08% (-0%)
40% less capital invested
Capital invested by funds: $1.05M → $633K (-$420K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$8.49K |
| 2 |
Morgan Stanley
New York
|
-$38 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
1
Courage Capital Management
Nashville,
Tennessee
| $621K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $6K | -$8.49K | -1,107 | -51% |
|
|
LTFS
3
Ladenburg Thalmann Financial Services
Miami,
Florida
| $6K | – | – | – |
|
|
4
Morgan Stanley
New York
| – | -$38 | -5 | -50% |
|
IMRN Hedge Fund Activity: Q4 2018 in Review
4 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Immuron (IMRN) for Q4 2018, worth a combined $633K — down 40% from $1.05M a quarter earlier.
Fund positioning in IMRN was balanced in Q4 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was UBS Group, cutting an estimated $8.49K.
- 4 institutional investors held Immuron (IMRN) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $633K of Immuron stock for Q4 2018, down 40% quarter-over-quarter.
- 0 funds opened new Immuron positions in Q4 2018 and 0 closed out.
- The largest Immuron seller in Q4 2018 was UBS Group, an estimated $8.49K sold.
Based on aggregated 13F filings for Q4 2018.